NCT01638442 - Crossover Trial of the Effect of a High-Fat Meal on the PK of Oral CHR 2797 in Healthy Male Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

September 30, 2012

Conditions

Healthy

Interventions

DRUG

CHR-2797

Two 60 mg capsules (120 mg dose) of CHR-2797 administered orally with 240 mL room temperature tap water after an approximately 10 hour fast.

DRUG

CHR-2797

"Two 60 mg capsules (120 mg dose) of CHR-2792 administered orally with 240 mL room temperature tap water within 30 minutes of receiving a high-fat meal.~\--------------------------------------------------------------------------------"

Trial Locations (1)

47710

Covance Clinical Research Unit Inc., Evansville